{"id":38206,"date":"2026-07-16T20:56:00","date_gmt":"2026-07-16T18:56:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=bc4b7ad3bfdbe8fd435bbaac2f7e36c2"},"modified":"2026-07-16T20:56:00","modified_gmt":"2026-07-16T18:56:00","slug":"mauna-kea-technologies-to-host-a-webinar-on-july-21-2026-to-discuss-its-first-half-business-activity","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=38206","title":{"rendered":"Mauna Kea Technologies to Host a Webinar on July 21, 2026 To Discuss Its First-Half Business Activity"},"content":{"rendered":"<p>PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News:<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260716753144\/en\/337855\/5\/mkt_logo_bg_1024-300dpi.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260716753144\/en\/337855\/5\/mkt_logo_bg_1024-300dpi.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260716753144\/en\/337855\/5\/mkt_logo_bg_1024-300dpi.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260716753144\/en\/337855\/21\/mkt_logo_bg_1024-300dpi.jpg\" \/><\/a><p>\n<b>Mauna Kea Technologies<\/b> <b>(Euronext Growth: ALMKT)<\/b>, inventor of Cellvizio<sup>\u00ae<\/sup>, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p\/nCLE) platform, announces that it will host a webinar for its shareholders and the financial community on <b>Tuesday, July 21, 2026.<\/b><\/p><p>\n<b>Sacha Loiseau<\/b>, Chairman and Chief Executive Officer, <b>and C\u00f4me de La Tour du Pin<\/b>, Chief Financial Officer of the Company, will provide live commentary on the key highlights of the first half of 2026. The presentation will be followed by a Q&amp;A session.<\/p><p>\nAdvance registration is required to participate in the event.<\/p><p class=\"bwalignc\">\n<b><i>Webinar for shareholders and investors \u2013 Tuesday, July 21 2026<\/i><\/b><\/p><p class=\"bwalignc\">\n5:50 pm. (CEST) \u2013 French Session:<span class=\"bwinvisible\"> <\/span><a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fapp.livestorm.co%2Feuroland-corporate%2Fmauna-kea-technologies-visioconference-investisseurs-ca-sa1&amp;esheet=54571920&amp;newsitemid=20260716753144&amp;lan=en-US&amp;anchor=Click+here+to+register&amp;index=1&amp;md5=96a26c3d47e9256fbf362c0011b80635\" rel=\"nofollow\" shape=\"rect\"><span class=\"bwinvisible\">Click here to register<\/span><\/a><\/p><p class=\"bwalignc\">\n<i>A replay will be available for registered participants.<\/i><\/p><p>\n<b>About Mauna Kea Technologies<\/b><\/p><p>\nMauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio\u00ae, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio\u00ae platform is used globally across a wide range of medical specialties and is making a transformative change in the way physicians diagnose and treat patients. For more information, visit <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.maunakeatech.com&amp;esheet=54571920&amp;newsitemid=20260716753144&amp;lan=en-US&amp;anchor=www.maunakeatech.com&amp;index=2&amp;md5=aa7425502529e98a16be6bc100e28105\" rel=\"nofollow\" shape=\"rect\">www.maunakeatech.com<\/a>.<\/p><br\/> <b>Contacts<\/b> <br\/><p>\n<b>Mauna Kea Technologies<\/b><br\/><a  href=\"mailto:investors@maunakeatech.com\" rel=\"nofollow\" shape=\"rect\">investors@maunakeatech.com<\/a><\/p><p>\n<b>NewCap - Investor Relations<\/b><br\/>Thomas Grojean\n<br\/>+33 (0)1 44 71 94 94\n<br\/><a  href=\"mailto:maunakea@newcap.eu\" rel=\"nofollow\" shape=\"rect\">maunakea@newcap.eu<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>PARIS &amp; BOSTON&#8211;(BUSINESS WIRE)&#8211;Regulatory News:<br \/>\nMauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio\u00ae, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p\/nCLE) platform, announces that it will host a webin&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-38206","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/38206","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=38206"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/38206\/revisions"}],"predecessor-version":[{"id":38207,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/38206\/revisions\/38207"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=38206"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=38206"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=38206"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}